Sale by Scott L Burrows (Chief Financial Officer)
12,500 shares · @ $71.37 · $892,125
Spyre Therapeutics, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $70.54
+8.1% in 7d after detection
Post-detection moves
1h
—
1d
-0.4%
3d
+5.2%
7d
+8.1%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS